ZIMV - ZimVie Inc

https://www.zimvie.com

Strong Sell Momentum: Bearish

Recent News

$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote

Benzinga • 1 week, 2 days ago • score: 0.15

NEW YORK, Sept. 05, 2025 ( GLOBE NEWSWIRE ) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC ( the "M&A Class Action Firm" ) , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.

Bullish

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ZimVie Inc. ( Nasdaq - ZIMV ) , Guess?, Inc. ( NYSE - GES ) , TEGNA Inc. ( NYSE - TGNA ) , NorthWestern Energy Group, Inc. ( Nasdaq - NWE )

Benzinga • 2 weeks, 5 days ago • score: 0.31

BALA CYNWYD, Pa., Aug. 26, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.

Neutral

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - RGLD, SNV, ZIMV, and MESA

Benzinga • 3 weeks, 6 days ago • score: 0.15

NEW YORK, Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC ( the "M&A Class Action Firm" ) , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.

Bullish

ZimVie ( ZIMV ) Q2 EPS Doubles to $0.26

Motley Fool • 1 month, 2 weeks ago • score: 0.32

ZimVie ( NASDAQ:ZIMV ) , a medical technology company focused on dental implant systems, released its earnings results on July 30, 2025. The company reported a clear improvement in profitability, with adjusted diluted EPS of $0.26 -- beating the consensus estimate of $0.21 ( non-GAAP ) .

Bullish

ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025

GlobeNewswire • 1 month, 3 weeks ago • score: 0.22

PALM BEACH GARDENS, Fla., July 25, 2025 ( GLOBE NEWSWIRE ) -- ZimVie Inc. ( Nasdaq: ZIMV ) , a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter 2025 and file its Quarterly Report on Form 10-Q after market close on ...

Bullish

ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025 - ZimVie ( NASDAQ:ZIMV )

Benzinga • 1 month, 3 weeks ago • score: 0.21

PALM BEACH GARDENS, Fla., July 25, 2025 ( GLOBE NEWSWIRE ) -- ZimVie Inc. ZIMV, a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter 2025 and file its Quarterly Report on Form 10-Q after market close on Wednesday, July ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-09 (Snapshot)

ZimVie Inc. focuses on the dental and spine markets.

52W High

$19.01

52W Low

$8.15

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

2.08

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

22.08

EV/EBITDA (<8 favorable)

16.23

EV/Revenue (<3 favorable)

1.57

P/S (TTM) (<3 favorable)

1.20

P/B (<3 favorable)

1.29

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

2.73%

Institutions (25–75% balanced)

83.75%

Shares Outstanding

28,210,700

Float

23,687,700

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

443,402,000

Gross Profit (TTM)

289,571,000

EPS (TTM)

-0.69

Profit Margin (>10% good)

-0.04%

Operating Margin (TTM) (higher better)

0.03%

ROE (TTM) (>15% strong)

-0.05%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.00

Momentum

Bearish momentum

Value

0.7736

0.8372

Trend

Falling

Signal Cross

No cross

As of

Sep. 04, 2025